A Study in Healthy Participants to Assess the Effect of Darunavir, Emtricitabine, and Tenofovir Alafenamide in the Presence of Cobicistat as Fixed Dose Combination (Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide) Compared With Co-administration of the Separate Agents

NCT04661397 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

37

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide FDC
DRUG: Darunavir
DRUG: Emtricitabine/Tenofovir Alafenamide
DRUG: Cobicistat

Sponsor

Janssen Research & Development, LLC